Medea Botanicals

Tibetan/Greater roseroot

Rhodiola crenulata

Other names: sol ba dmar po, Tibetan/Greater roseroot

Tibetan

Safety information

Safety information

Toxicity: Generally low at standard extract doses; high doses may cause irritability, insomnia, jitteriness.

Contraindications: Bipolar/agitation states (stimulating), pregnancy/lactation (insufficient data). Use cautiously before sleep.

Interactions: Possible interactions with antidepressants/MAOIs and stimulants (theoretical); may affect CYP-metabolised drugs (preclinical signals).

Pregnancy & breastfeeding: Insufficient data.

Evidence level

Preclinical

Supported by laboratory or animal studies; not yet confirmed in humans.

Preparations

decoction/powder/tincture/extract · root and rhizome

Part used: root and rhizome

Traditional use: Plateau adaptogen for 'lung/wind' weakness, fatigue, tonic to aid high-altitude acclimatization

Proposed mechanism: Salidroside and tyrosol (low in rosavins vs European R. rosea) — HIF-1α modulation, improved mitochondrial/oxidative handling under hypoxia, antioxidant-enzyme induction, anti-inflammatory/cardioprotective signalling (preclinical)

Dosage note (descriptive only): Decoction/powder of root-and-rhizome in compound formulas; extract studies standardised to salidroside; formula-/product-dependent

Evidence:Preclinical

General preparation guide →

Associated conditions

Nutritional notes

Not a nutritional food; bioactives are salidroside, rosavins, tyrosol.

Healing traditions

Tibetan
Sources (2)

  1. Ning et al. 2026, J Ethnopharmacol (PMID 41936838)
  2. Gao et al. 2026, Front Pharmacol (PMID 42222156)

All sources →

Not medical advice. Consult a qualified healthcare professional before using any plant or preparation.